This functionality is implemented using Javascript. It cannot work without it, etc...

We are loading the information...

Skip to main content

Medical Policies

Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.

Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.

ID Title Last Review Next Review Description Access
M5.001.021 Biological Treatments for Refractory Myasthenia Gravis Jun 25, 2024 Jun 20, 2025 Myasthenia gravis is an autoimmune neuromuscular disorder characterized by fluctuating motor weakness... View
M5.001.022 Ultomiris® (ravulizumab-cwvz) Oct 09, 2024 Jun 20, 2025 Ravulizumab-cwvz is a complement inhibitor indicated as a treatment for adult patients, 18 years and older,... View
M5.001.023 Soliris (eculizumab) Aug 22, 2024 Aug 20, 2025 Soliris is a complement inhibitor indicated for the treatment of patients with paroxysmal nocturnal... View
M5.001.024 Adstiladrin® (nadofaragene firadenovec-vncg) Feb 20, 2025 Oct 20, 2025 Adstiladrin is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult... View

Want to be up to date on topics like health, trending news, useful tips, lifestyles and more?

Subscribe to our blog and don't miss out on anything!

Subscribe to the blog

We want to personalize the content according to your preferences

Please select one or more categories to continue

Thanks for subscribing!

You will receive information of interest in your email.

787-277-6653 787-474-6326